| Stage | BELFB | % of rev | MAMA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $211M | 100.00% | $55M | 100.00% | BELFB ×3.86 |
| Gross profit | $84M | 39.85% | $13M | 23.96% | BELFB +15.9pp |
| Operating income | $38M | 18.24% | $3M | 5.48% | BELFB +12.8pp |
| Pre-tax income | $38M | 17.92% | $3M | 6.05% | BELFB +11.9pp |
| Net income | $34M | 16.13% | $3M | 4.70% | BELFB +11.4pp |
| Stage | BELFB | MAMA | Gap · A − B |
|---|---|---|---|
| Revenue | $211M100.00% | $55M100.00% | BELFB ×3.86 |
| Gross profit | 39.85%$84M | 23.96%$13M | BELFB +15.9pp |
| Operating income | 18.24%$38M | 5.48%$3M | BELFB +12.8pp |
| Pre-tax income | 17.92%$38M | 6.05%$3M | BELFB +11.9pp |
| Net income |
| 16.13%$34M |
| 4.70%$3M |
| BELFB +11.4pp |
None
No disclosed counterparties: BELFB.